25 related articles for article (PubMed ID: 10422327)
1. First total synthesis and biological screening of hymenamide E.
Dahiya R; Pathak D; Himaja M; Bhatt S
Acta Pharm; 2006 Dec; 56(4):399-415. PubMed ID: 19839133
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activity studies of 1,3,4-thiadiazolo[2,3-c]-as-triazines.
Kalluraya B; Sreenivasa S; Banji D
Boll Chim Farm; 1997 Mar; 136(3):266-71. PubMed ID: 9164168
[TBL] [Abstract][Full Text] [Related]
3. Synthetic studies on cyclic octapeptides: Yunnanin F and Hymenistatin.
Poojary B; Belagali SL
Eur J Med Chem; 2005 Apr; 40(4):407-12. PubMed ID: 15804540
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of pseudostellarin B.
Poojary B; Kumar KH; Belagali SL
Farmaco; 2001 Apr; 56(4):331-4. PubMed ID: 11421263
[TBL] [Abstract][Full Text] [Related]
5. Novel dihydropyrimidines and its pyrazole derivatives: synthesis and pharmacological screening.
Ramesh B; Bhalgat CM
Eur J Med Chem; 2011 May; 46(5):1882-91. PubMed ID: 21414695
[TBL] [Abstract][Full Text] [Related]
6. (Nitro) hymenamide A, unusual biologically active cyclic peptide.
Belagali SL; Himaja M; Kumar LH; Thomas R; Prakasini SR; Poojary B
Boll Chim Farm; 1999 Apr; 138(4):160-4. PubMed ID: 10422327
[TBL] [Abstract][Full Text] [Related]
7. Recent progress in the discovery of macrocyclic compounds as potential anti-infective therapeutics.
Obrecht D; Robinson JA; Bernardini F; Bisang C; DeMarco SJ; Moehle K; Gombert FO
Curr Med Chem; 2009; 16(1):42-65. PubMed ID: 19149562
[TBL] [Abstract][Full Text] [Related]
8. Design of iodine-lithium-alpha-dextrin liquid crystal with potent antimicrobial and anti-inflammatory properties.
Davtyan TK; Mkhitaryan LM; Gabrielyan ES
Curr Pharm Des; 2009; 15(11):1172-86. PubMed ID: 19355958
[TBL] [Abstract][Full Text] [Related]
9. Cyclopeptide alkaloids.
Gournelis DC; Laskaris GG; Verpoorte R
Fortschr Chem Org Naturst; 1998; 75():1-179. PubMed ID: 9739622
[No Abstract] [Full Text] [Related]
10. Advantage and issue of silkworm model for development of anti-infective agents.
Hamamoto H
Jpn J Antibiot; 2016 Oct; 69(5):301-308. PubMed ID: 30226943
[TBL] [Abstract][Full Text] [Related]
11. Mode of action of anti-infective agents: focus on oxidative stress and electron transfer.
Kovacic P; Becvar LE
Curr Pharm Des; 2000 Jan; 6(2):143-67. PubMed ID: 10637374
[TBL] [Abstract][Full Text] [Related]
12. Biologically active quinazolones.
Sinha S; Srivastava M
Prog Drug Res; 1994; 43():143-238. PubMed ID: 7855250
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
